Want to see AU:4DX full AI Analyst Report?

4DMedical Ltd (4DX) Price & Analysis

210 Followers

4DX Stock Chart & Stats

AU$3.11

AU$0.17(5.47%)

At close: Jul 27 4:00 PM EDT

AU$3.11

AU$0.17(5.47%)

Day’s Range― - ―

52-Week RangeAU$0.45 - AU$7.55

Previous CloseN/A

Volume3.54M

Average Volume (3M)10.77M

Market Cap

AU$2.64B

Enterprise ValueAU$1.89K

Total Cash (Recent Filing)AU$56.76M

Total Debt (Recent Filing)AU$6.42M

Price to Earnings (P/E)―

Beta2.43

Next Earnings

Aug 27, 2026

EPS Estimate

-0.04

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.32

Shares Outstanding599,638,850

10 Day Avg. Volume5,850,211

30 Day Avg. Volume10,774,582

Financial Highlights & Ratios

PEG Ratio-0.06

Price to Book (P/B)0.80

Price to Sales (P/S)8.81

P/FCF Ratio-1.49

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

AU$4.50

Price Target Upside44.69% Upside

Rating ConsensusHold

Number of Analyst Covering2

EPS Forecast (FY)-0.06

Revenue Forecast (FY)AU$22.27M

Bulls Say, Bears Say

Bulls Say

Software-based Lung Imaging Platform4DMedical’s core product is a software/AI-enabled platform for quantifying regional lung ventilation. Software delivery supports rapid feature updates, scalability across installations, and clinical integration, creating durable differentiation versus pure hardware vendors and enabling ongoing clinical adoption.

Diverse Recurring Revenue StreamsThe company’s mix of licensing/subscriptions, per-scan usage fees and services supports recurring and usage-based revenue that scales with clinical adoption. This model provides structural revenue visibility and upside as hospitals increase scan volumes and renew contracts over multi-year adoption cycles.

Conservative Leverage On Balance SheetA low debt-to-equity profile and stable equity ratio reduce solvency risk and preserve financing optionality, giving the company runway to invest in sales, regulatory steps and product refinement without immediate pressure from high interest obligations—important for a growth-stage medtech software business.

Bears Say

Declining Revenue TrendA year-over-year revenue decline indicates challenges in customer acquisition, retention or utilization. For a software/usage-based model, falling top-line undermines scale economics, reduces per-customer amortization of fixed costs, and curtails funds available for R&D and clinical validation needed to sustain long-term adoption.

Persistent Negative ProfitabilitySustained net losses and negative EBIT margins signal the company has not yet converted product adoption into profitable operations. Continued unprofitability pressures equity, can force dilution via capital raises, and limits ability to self-fund commercial expansion and regulatory activities essential for durable market penetration.

Negative Operating And Free Cash FlowsOngoing negative operating and free cash flows imply the business relies on external financing to sustain operations. This constrains the pace of commercial expansion and product development, increases execution risk if capital markets tighten, and makes long-term scaling dependent on successful capital raises or material margin improvement.

4DMedical Ltd News

4DMedical accelerates global rollout of CT:VQ™ as revenue and scan volumes surge

4DMedical Ltd ( ($AU:4DX) ) has shared an update. 4DMedical reported a solid quarter with FY26 operating revenue...

13d ago

4DX

4DMedical Issues New Shares on Option Exercise, Affirms Regulatory Compliance

4DMedical Ltd ( ($AU:4DX) ) has shared an update. Following the recent exercise of options under its Long...

1M ago

4DX

4DMedical Adds 1.63 Million New Shares to ASX Quotation

4DMedical Ltd ( ($AU:4DX) ) has provided an announcement. 4DMedical Ltd has applied for quotation on the ASX...

1M ago

4DX

4DMedical Expands ASX-Quoted Share Base Through New Issuance

4DMedical Ltd ( ($AU:4DX) ) just unveiled an update. 4DMedical Ltd has applied for the quotation of additional...

1M ago

4DX

State Street Group Ceases to Be Substantial Holder in 4DMedical

An update from 4DMedical Ltd ( ($AU:4DX) ) is now available. State Street Corporation and several of its...

1M ago

4DX

4DMedical Issues New Shares While Affirming Compliance and Transparency

The latest announcement is out from 4DMedical Ltd ( ($AU:4DX) ). 4DMedical Limited, a global medtech firm listed...

1M ago

4DX

4DMedical Seeks ASX Quotation for Additional Ordinary Shares

An announcement from 4DMedical Ltd ( ($AU:4DX) ) is now available. 4DMedical Ltd has applied to the ASX...

1M ago

4DX

4DMedical Seeks ASX Quotation for Additional Ordinary Shares

An announcement from 4DMedical Ltd ( ($AU:4DX) ) is now available. 4DMedical Ltd has applied to the ASX...

1M ago

4DX

4DMedical directors boost holdings as AI lung imaging strategy advances

The latest announcement is out from 4DMedical Ltd ( ($AU:4DX) ). 4DMedical has disclosed changes in director shareholdings...

2M ago

4DX

4DMedical Issues New Shares Under Incentive Plan While Confirming Regulatory Compliance

4DMedical Ltd ( ($AU:4DX) ) has issued an update. 4DMedical Limited has issued 1,677,016 fully paid ordinary shares...

2M ago

4DX

4DX FAQ

What was 4DMedical Ltd’s price range in the past 12 months?

4DMedical Ltd lowest share price was AU$0.45 and its highest was AU$7.55 in the past 12 months.

What is 4DMedical Ltd’s market cap?

4DMedical Ltd’s market cap is AU$2.64B.

When is 4DMedical Ltd’s upcoming earnings report date?

4DMedical Ltd’s upcoming earnings report date is Aug 27, 2026 which is in 14 days.

How were 4DMedical Ltd’s earnings last quarter?

4DMedical Ltd released its earnings results on Feb 26, 2026. The company reported -AU$0.259 earnings per share for the quarter, missing the consensus estimate of -AU$0.036 by -AU$0.223.

Is 4DMedical Ltd overvalued?

According to Wall Street analysts 4DMedical Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does 4DMedical Ltd pay dividends?

4DMedical Ltd does not currently pay dividends.

What is 4DMedical Ltd’s EPS estimate?

4DMedical Ltd’s EPS estimate is -0.04.

How many shares outstanding does 4DMedical Ltd have?

4DMedical Ltd has 599,638,850 shares outstanding.

What happened to 4DMedical Ltd’s price movement after its last earnings report?

4DMedical Ltd reported an EPS of -AU$0.259 in its last earnings report, missing expectations of -AU$0.036. Following the earnings report the stock price went up 7.527%.

Which hedge fund is a major shareholder of 4DMedical Ltd?

Currently, no hedge funds are holding shares in AU:4DX

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

4DMedical Ltd Stock Smart Score

Neutral

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

36.79%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

4DMedical Ltd

Incorporated in 2012 and headquartered in Carlton, Australia, 4DMedical Limited operates as a medical technology enterprise across Australia and the United States. The company primarily focuses on bringing to market its innovative XV Technology, an advanced system for four-dimensional lung imaging. Beyond this core offering, its suite of products includes a software-as-a-service (SaaS) delivery model, specialized XV lung ventilation analysis software, and Permetium—a preclinical imaging system designed to quantify regional changes in pulmonary function. Additionally, the firm provides the AccuVent 200, a ventilator tailored for small animals.

4DMedical Ltd (4DX) Earnings & Revenues

Historic Earnings Reports

4DX Stock 12 Month Forecast

Average Price Target

AU$4.50

▲(44.69% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"AU$1","3":"AU$3","5":"AU$5","7":"AU$7","-1":"-AU$1"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">AU$6.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">AU$4.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">AU$3.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,1,3,5,7],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.63,3.812307692307692,3.9946153846153845,4.176923076923077,4.359230769230769,4.541538461538462,4.723846153846154,4.906153846153846,5.088461538461538,5.270769230769231,5.453076923076923,5.635384615384615,5.817692307692308,{"y":6,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.63,3.6969230769230768,3.7638461538461536,3.8307692307692305,3.897692307692308,3.9646153846153847,4.031538461538462,4.098461538461539,4.165384615384616,4.2323076923076925,4.299230769230769,4.366153846153846,4.433076923076923,{"y":4.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.63,3.5815384615384613,3.533076923076923,3.4846153846153847,3.436153846153846,3.3876923076923076,3.339230769230769,3.290769230769231,3.2423076923076923,3.193846153846154,3.1453846153846152,3.096923076923077,3.0484615384615386,{"y":3,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.3,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.78,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.26,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.74,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.74,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.54,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.21,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.22,"date":1772323200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":5.95,"date":1775001600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.02,"date":1777593600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":4.09,"date":1780272000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.04,"date":1782864000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3.63,"date":1785542400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >